Evaluation of Bronchiectasis Empowerment Tool (BET)

Not Applicable

Completed

• Conditions: Disease: Respiratory, All Diseases; Respiratory; Topic: Primary Care, Respiratory disorders; Subtopic: Respiratory (all Subtopics), Respiratory disorders

• Registration Number: ISRCTN18400127
• Lead Sponsor: orfolk and Norwich University Hospital NHS Trust

Brief Summary

2017 Abstract results in http://thorax.bmj.com/content/72/Suppl_3/A29.2 results presented at British Thoracic Society Winter Meeting 2020 Results article in https://doi.org/10.1177/1479973120948077 (added 10/07/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-06-24
• Study Completion: 2016-04-30
• Last Update Posted: 25 July 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 220

Inclusion Criteria

1. Male or female, aged more than 18 years
2. High Resolution Computed tomography (HRCT) diagnosis of bronchiectasis
3. At least one exacerbation of bronchiectasis within the previous 12 months
Target Gender: Male & Female ; Lower Age Limit 18 years

Exclusion Criteria

1. Cystic fibrosis related bronchiectasis or traction bronchiectasis
2. Severe or uncontrolled co-morbid disease, which is likely to affect the outcome of the study
3. Abnormalities in cognitive functioning that would limit the patient’s ability to undertake the procedures
4. Currently using a written patient self-management plan or involved in the design of BET
5. Unable to provide written informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Self Efficacy; Timepoint(s): By questionnaire at baseline and then every 3 months for a 12 mth period, 5 time points in total.

Secondary Outcome Measures

Name	Time	Method
1. Change from baseline in health related quality of life measured using the St Georges Respiratory Questionnaire<br>2. Changes in disease understanding assessed using the Lung Information Needs Questionnaire (LINQ) and non validated questionnaire <br>3. Difference in the number of exacerbations treated with appropriate antibiotic therapy targeted against sputum bacterial sensitivities during the study obtained from microbiology sensitivity data and prescription data from questionnaires and medication packet inserts returned<br>4. Difference in the number of unscheduled, emergency or out of hours healthcare contacts for bronchiectasis over the 12 month duration of the study<br>5. Difference in number and type of all routine and emergency NHS contacts over the 12 month duration of the study<br>6. Incremental Quality Adjusted Life Years (QALYs) accrued (estimated from EQ-5D data[16]) from baseline<br>7. A qualitative evaluation of BET from a patient and health care professional point of view